
Biography Senior Computational Scientist with 18 years of experience in developing sophisticated, analytical, bioinformatics algorithms, pipelines, and portals as well as applying them to understand complex biological data. Credo: the properly conducted analysis of combined clinical, molecular and genomic data can be easily translated into clinical applications to increase the success rate of drug developments…
Bio Details →Biography Dr. Lippa has served as Executive Chairman since March, 2013 and Chief Scientific Officer since August, 2015. From March, 2013 until August, 2015 and from September, 2018 until May, 2020, he also served as President and Chief Executive Officer, respectively. He is a Senior Managing Director and founder of T Morgen Capital LLC through…
Bio Details →Biography Over a decade of experience in identifying unique differentiated opportunities, and building/implementing plans and teams to create value for commercial success. Significant expertise in leading cross-functional teams in the deployment of AI analytics/machine learning integration to domain-specific RWD/RWE environments enabling rapid, synchronous translation of early discovery R&D, target tractability, drug discovery & pharmaceutical development….
Bio Details →